Neovasc Inc. Operating CF/Net income

Operating CF/Net income of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating CF/Net income growth rates and interactive chart. Calculated as operating cash flow divided by net income to common shareholders. Also called income quality ratio. A ratio of greater than 1.0 usually indicates high-quality income, while a ratio of less than 1.0 indicates low-quality.

Highlights and Quick Summary

  • Operating CF/Net income for the quarter ending March 31, 2022 was 0.69 (a -8.24% decrease compared to previous quarter)
  • Year-over-year quarterly Operating CF/Net income decreased by -10.51%
  • Annual Operating CF/Net income for 2021 was 1.11 (a 4.85% increase from previous year)
  • Annual Operating CF/Net income for 2020 was 1.06 (a 55.16% increase from previous year)
  • Annual Operating CF/Net income for 2019 was 0.68 (a 223.26% increase from previous year)
  • Twelve month Operating CF/Net income ending March 31, 2022 was 0.79 (a -29.15% decrease compared to previous quarter)
  • Twelve month trailing Operating CF/Net income decreased by -35.32% year-over-year
Trailing Operating CF/Net income for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
0.79 1.11 1.3 1.22
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating CF/Net income of Neovasc Inc.

Most recent Operating CF/Net incomeof NVCN including historical data for past 10 years.

Interactive Chart of Operating CF/Net income of Neovasc Inc.

Neovasc Inc. Operating CF/Net income for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.69 – – – –
2021 0.75 0.98 0.77 4.0 1.11
2020 1.57 0.87 0.71 1.67 1.06
2019 0.48 1.09 0.64 0.73 0.68
2018 -0.51 0.37 0.12 0.09 0.21
2017 24.74 0.86 0.73 0.8 6.05
2016 -0.18 0.38 0.13 1.0 0.46
2015 0.84 0.84 0.77 0.7 0.8
2014 0.45 0.84 0.22 2.03 0.47
2013 0.5 1.07 0.92 0.47 0.69
2012 -0.1 0.39 0.41 0.48 5.8
2011 2.03 – – – 0.52

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
© stockrow.com